Lee Yuchun's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Jan 27, 2023
- Accession no.
- 0001209191-23-005234
- Filed
- Jan 27, 2023
- Trade date
- Jan 25-26, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.53M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee YuchunCIK 0001334365 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2023 | Common Stock | MOption exerciseAcquired | +4,000 | $72.14 | +$288,560 | 5,875 | Direct | |
| Jan 25, 2023 | Common Stock | SSaleDisposed | −800 | $312.80F2,F3 | −$250,240 | 5,075 | Direct | |
| Jan 25, 2023 | Common Stock | SSaleDisposed | −2,621 | $314.10F2,F4 | −$823,256.1 | 2,454 | Direct | |
| Jan 25, 2023 | Common Stock | SSaleDisposed | −579 | $314.95F2,F5 | −$182,356.05 | 1,875 | Direct | |
| Jan 26, 2023 | Common Stock | MOption exerciseAcquired | +4,000 | $72.14 | +$288,560 | 5,875 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −302 | $315.42F2,F6 | −$95,256.84 | 5,573 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −1,140 | $316.82F2,F7 | −$361,174.8 | 4,433 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −1,000 | $317.95F2,F8 | −$317,950 | 3,433 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −478 | $319.25F2,F9 | −$152,601.5 | 2,955 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −400 | $320.25F2,F10 | −$128,100 | 2,555 | Direct | |
| Jan 26, 2023 | Common Stock | SSaleDisposed | −680 | $320.94F2,F11 | −$218,239.2 | 1,875 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2023 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 5,429 | Direct | |
| Jan 26, 2023 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 1,429 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 9 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $312.80 (range $312.41 to $313.06).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $314.10 (range $313.53 to $314.50).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $314.95 (range $314.58 to $315.14).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $315.42 (range $315.23 to $315.66).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $316.82 (range $316.23 to $317.16).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $317.95 (range $317.43 to $318.35).
Referenced by the price of 1 transaction in Table I.
- F9
Open market sales reported on this line occurred at a weighted average price of $319.25 (range $318.79 to $319.56).
Referenced by the price of 1 transaction in Table I.
- F10
Open market sales reported on this line occurred at a weighted average price of $320.25 (range $319.80 to $320.77).
Referenced by the price of 1 transaction in Table I.
- F11
Open market sales reported on this line occurred at a weighted average price of $320.94 (range $320.89 to $320.99).
Referenced by the price of 1 transaction in Table I.